Related Experiment Video
Updated: Jun 25, 2026
08:30
Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
Published on: April 19, 2011
Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade
D J Duncker1, N S van Zon, T J Pavek
1Department of Internal Medicine, University of Minnesota Medical School, Minneapolis 55455.
The Journal of Clinical Investigation
|January 1, 1995
Summary
Exercise-induced coronary vasodilation involves K(ATP)+ channels and adenosine. Blocking these channels during exercise reveals adenosine
Area of Science:
- Cardiovascular Physiology
- Exercise Physiology
- Myocardial Blood Flow Regulation
Background:
- The precise mechanisms of coronary vasodilation during exercise remain incompletely understood.
- Previous research indicated K(ATP)+ channel blockade affects resting coronary flow but not exercise-induced increases.
- Adenosine's role in hypoperfused myocardium suggests a compensatory mechanism for vasodilation.
Purpose of the Study:
- To investigate if adenosine counteracts hypoperfusion caused by K(ATP)+ channel blockade during exercise.
- To elucidate the interplay between K(ATP)+ channels and adenosine in regulating coronary blood flow during physical activity.
Main Methods:
- Utilized an 11-dog model, measuring coronary blood flow and myocardial oxygen extraction at rest and during exercise.
- Administered intracoronary glibenclamide (K(ATP)+ channel blocker) and intravenous 8-phenyltheophylline (adenosine receptor antagonist).
- Assessed coronary venous oxygen tension to evaluate oxygen supply-demand mismatch.
Main Results:
- Glibenclamide reduced resting coronary blood flow and increased myocardial oxygen extraction during peak exercise.
- Adenosine receptor blockade, combined with glibenclamide, attenuated exercise-induced coronary vasodilation.
- Combined blockade significantly worsened the coronary oxygen supply-demand mismatch.
Conclusions:
- K+ATP channels play a role in modulating coronary vasomotor tone at rest and during exercise.
- In the presence of K(ATP)+ channel blockade, adenosine acts as an alternative pathway for coronary vasodilation.
- Adenosine compensates for hypoperfusion by facilitating coronary vasodilation when K(ATP)+ channels are inhibited during exercise.
Related Concept Videos
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:29Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...